Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXpanded CELL ENdocardiac Transplantation (EXCELLENT)

NCT02669810 is registered in ClinicalTrials.gov with CellProthera as lead sponsor.

NCT NCT02669810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02669810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXpanded CELL ENdocardiac Transplantation (EXCELLENT)
Lead sponsor
CellProthera
Phase
Phase 2
Overall status
Completed
Start date
February 10, 2016
Completion date
March 15, 2024
Enrollment
49 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction